Elizabeth O. Lillie

The N-Of-1 Clinical Trial: The Ultimate Strategy For Individualizing Medicine?

Elizabeth O. Lillie, Bradley Patay, Joel Diamant et al. · Personalized Medicine · 2011 · 682 citations

Individual Patient, Clinical Endpoint, Ultimate Strategy +16

Platelet Reactivity and Cardiovascular Outcomes After Percutaneous Coronary Intervention

Matthew J. Price, Dominick J. Angiolillo, Paul S. Teirstein et al. · Circulation · 2011 · 396 citations

Is Pocket Mobile Echocardiography the Next-Generation Stethoscope? A Cross-sectional Comparison of Rapidly Acquired Images With Standard Transthoracic Echocardiography

Max Liebo, Rachel L. Israel, Elizabeth O. Lillie et al. · Annals of Internal Medicine · 2011 · 158 citations · Full text

Influence of Genetic Polymorphisms on the Effect of High- and Standard-Dose Clopidogrel After Percutaneous Coronary Intervention

Matthew J. Price, Sarah S. Murray, Dominick J. Angiolillo et al. · Journal of the American College of Cardiology · 2012 · 138 citations

C-reactive protein, an ‘intermediate phenotype’ for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/β-adrenergic pathway loci

Jennifer Wessel, Guillermo Moratorio, Fangwen Rao et al. · Journal of Hypertension · 2007 · 98 citations